Ken Griffin Embecta Corp. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Embecta Corp. stock. As of the latest transaction made, Citadel Advisors LLC holds 7,900 shares of EMBC stock, worth $106,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,900

Previous 20,500 61.46%

Holding current value

$106,650

Previous $289,000 43.25%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$12.51 - $20.83 $659,014 - $1.1 Million	-52,679 Reduced 35.11%	97,364 $2.02 Million
Q3 2024 Nov 14, 2024	SELL	$11.46 - $16.56 $3.06 Million - $4.43 Million	-267,244 Reduced 64.04%	150,043 $2.12 Million
Q2 2024 Aug 14, 2024	BUY	$10.13 - $14.6 $802,407 - $1.16 Million	79,211 Added 23.43%	417,287 $5.22 Million
Q1 2024 May 15, 2024	SELL	$12.35 - $19.33 $2.9 Million - $4.54 Million	-234,930 Reduced 41.0%	338,076 $4.49 Million
Q4 2023 Feb 14, 2024	SELL	$12.87 - $19.09 $783,731 - $1.16 Million	-60,896 Reduced 9.61%	573,006 $10.8 Million
Q3 2023 Nov 14, 2023	BUY	$15.0 - $22.17 $5.79 Million - $8.56 Million	386,120 Added 155.83%	633,902 $9.54 Million
Q2 2023 Aug 14, 2023	BUY	$21.6 - $30.69 $4.84 Million - $6.87 Million	223,974 Added 940.75%	247,782 $5.35 Million
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $338,598 - $480,965	14,677 Added 160.74%	23,808 $669,000
Q4 2022 Feb 14, 2023	SELL	$25.29 - $35.48 $393,082 - $551,465	-15,543 Reduced 62.99%	9,131 $230,000
Q3 2022 Nov 14, 2022	BUY	$24.0 - $33.42 $592,176 - $824,605	24,674 New	24,674 $710,000

Others Institutions Holding EMBC

# of Institutions

406

Shares Held

52.4M

Call Options Held

120K

Put Options Held

66.8K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $781M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account